Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling plus topical tranexamic acid vs microneedling in macular amyloidosis
IRCT20220101053588N1Phase 3Completed
- Sponsor
- Skin Research Center of Shahid Beheshti University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Macular Amyloidosis (2 arms), sponsored by Skin Research Center of Shahid Beheshti University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20220101053588N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220101053588N1.